Advanced Medical Isotope Revenue 2013-2025 | RDGL

Advanced Medical Isotope revenue from 2013 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Advanced Medical Isotope Annual Revenue
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
Advanced Medical Isotope Quarterly Revenue
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31
2021-09-30 $0
2021-06-30
2021-03-31
2020-12-31
2020-09-30 $0
2020-06-30
2020-03-31
2019-12-31 $0
2019-09-30 $0
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30
2015-03-31 $0
2014-12-31
2014-09-30
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
Sector Industry Market Cap Revenue
Finance Finance - SBIC & Commercial $0.056B $0.000B
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) United States $15.508B 9.97
Blackstone Secured Lending Fund (BXSL) United States $7.296B 9.22
Main Street Capital (MAIN) United States $5.177B 14.39
Golub Capital BDC (GBDC) United States $4.070B 8.83
Hercules Capital (HTGC) United States $3.163B 9.20
Sixth Street Specialty Lending (TSLX) United States $2.206B 10.03
Morgan Stanley Direct Lending Fund (MSDL) United States $1.717B 8.21
Goldman Sachs BDC (GSBD) United States $1.362B 5.72
New Mountain Finance (NMFC) United States $1.166B 8.07
Kayne Anderson BDC (KBDC) United States $1.120B 8.27
Bain Capital Specialty Finance (BCSF) United States $1.022B 7.65
BARINGS BDC, INC (BBDC) United States $0.962B 7.48
Amalgamated Financial (AMAL) United States $0.957B 8.83
Trinity Capital (TRIN) United States $0.944B 6.92
Nuveen Churchill Direct Lending (NCDL) United States $0.822B 7.29
Carlyle Secured Lending (CGBD) United States $0.720B 7.51
Fidus Investment (FDUS) United States $0.715B 9.11
BLACKROCK TCP CAPITAL CORP (TCPC) United States $0.668B 5.17
Gladstone Capital (GLAD) United States $0.603B 13.04
Gladstone Investment (GAIN) United States $0.515B 14.41
CION Investment (CION) United States $0.482B 5.94
Palmer Square Capital BDC (PSBD) United States $0.451B 7.65
PennantPark Investment (PNNT) United States $0.449B 8.18
Stellus Capital Investment (SCM) United States $0.386B 8.28
Runway Growth Finance (RWAY) United States $0.378B 6.36
Saratoga Investment Corp (SAR) United States $0.370B 6.27
Horizon Technology Finance (HRZN) United States $0.304B 6.18
TriplePoint Venture Growth BDC (TPVG) United States $0.294B 5.76
Chicago Atlantic BDC (LIEN) United States $0.230B 38.71
Medallion Financial (MFIN) United States $0.221B 5.93
WhiteHorse Finance (WHF) United States $0.213B 6.45
Oxford Square Capital (OXSQ) United States $0.166B 5.66
PhenixFIN (PFX) United States $0.096B 18.85
Logan Ridge Finance (LRFC) United States $0.046B 11.20
Rand Capital (RAND) United States $0.044B 8.54
Investcorp Credit Management BDC (ICMB) United States $0.041B 8.09
OFS Capital (OFS) United States $0.000B 8.20
SLR Investment (SLRC) United States $0.000B 9.72
FS KKR Capital (FSK) United States $0.000B 7.68
Crescent Capital BDC (CCAP) United States $0.000B 6.69